Table 3.
Type of graft | Lead author | Year | Preoperative |
Postoperative |
Change | P value | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IIEF score (SD; range) | Erectile status, % (n/N) |
IIEF score (SD; range) | Erectile status, % (n/N) |
ED change, % (n/N) |
||||||||||
Unaided | Aided | ED present | Unaided | Aided | Absent | Worsened | Improved | |||||||
Xenograft | Sayedahmed19 | 2017 | 16 (±3.5; NM) | NM | NM | NM | 20 (±4.2; NM) | 67.4 (29/43) | 20.9 (9/43) | 11.6 (5/43) | 7.0 (3/43) | 69.8 (30/43) | ↑ | <.001 |
Cosentino20 | 2016 | – | 86.7 (39/44) | NM | 11.4 (5/44) | – | 95.5 (42/44) | 4.6 (2/44) | 0.0 (0/44) | 4.6 (2/44) | NM | ↑ | – | |
Knoll21 | 2007 | – | NM | NM | 0.0 (0/162) | – | 80.3 (130/162) | 15.4 (25/162) | 4.3 (7/162) | NM | NM | ↓ | – | |
Sansalone22 | 2011 | 16 (NM; 15–21)† | NM | NM | NM | 22.5 (NM; NM) | 66.9 (105/157) | 33.1 (52/157) | 0.0 (0/157) | NM | NM | ↑ | NM | |
Allograft | Sampaio23 | 2002 | – | NM | NM | NM | – | NM | NM | NM | 15.0 (6/40) | NM | ↓ | – |
Autograft | Kadioglu24 | 2018 | – | NM | NM | 25.7 (37/144) | – | 66.7 (96/144) | 21.5 (31/144) | 11.8 (17/144) | NM | NM | ↓ | – |
Kalsi25 | 2005 | – | 60.2 (68/113) | 39.8 (45/113) | NM | – | 65.5 (74/113) | 11.6 (13/113) | 2.7 (3/113) | 9.7 (11/113) | 3.5 (4/113) | ↓ | – | |
Montorsi26 | 2000 | – | NM | NM | 0.0 (0/50) | – | NM | NM | NM | 6.0 (3/50) | 0.0 (0/50) | ↓ | – | |
Akkus27 | 2001 | – | NM | NM | 0.0 (0/58) | – | NM | NM | 0.0 (0/58) | 6.9 (4/58) | 0.0 (0/58) | ↓ | – | |
El Sakka13 | 1998 | – | NM | NM | 34.8 (39/112) | – | NM | NM | NM | 24.1 (27/112) | 7.1 (8/112) | ↓ | – | |
Multiple | Flores15 | 2011 | 23 (±4; NM) | 35.7 (20/56) | 64.3 (36/56) | NM | 17 (±9; NM) | NM | NM | NM | NM | NM | ↓ | <.01 |
Chung28 | 2011 | 15.1 (NM; 6–20) | NM | 14.0 (12/86) | NM | 10.8 (NM; 2–15) | NM | 67.4 (31/46) | NM | NM | NM | ↓ | <.01∗ | |
Range | – | – | 15.1–23 | 35.7–86.7 | 14.0–64.3 | 0.0–34.8 | 10.8–22.5 | 65.5–95.5 | 4.6–67.4 | 0.0–11.8 | 4.6–24.1 | 0–69.8 | – | – |
Erectile status absent constitutes erectile function insufficient for sexual intercourse; ↑ indicates overall improvement; ↓, overall worsening.
For the penile rigidity domain, sexual desire and intercourse unchanged (P > .05).
Only 89 patients completed the IIEF.